Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement



Status:Active, not recruiting
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:Any
Updated:10/24/2018
Start Date:August 2012
End Date:April 2021

Use our guide to learn which trials are right for you!

Medtronic CoreValve® U.S. Expanded Use Study

To evaluate the safety and efficacy of the Medtronic CoreValve® System for the treatment of
symptomatic severe aortic stenosis in subjects with significant comorbidities in whom the
risk of surgical aortic valve replacement has a predicted operative mortality or serious,
irreversible morbidity risk of ≥50% at 30 days.

The primary objective of the study is to evaluate the safety and effectiveness of the
Medtronic CoreValve® System (MCS) in a subset of subjects excluded from the U.S. Extreme Risk
Pivotal Trial population due to one or more additional co-morbidities, as measured by a
composite of all-cause death or major stroke at 12 months, in the treatment of symptomatic
severe aortic stenosis in subjects necessitating aortic valve replacement. Subjects enrolled
in this study have a predicted operative mortality or serious, irreversible morbidity risk of
≥50% at 30 days associated with surgical aortic valve replacement.

Inclusion Criteria:

- Subject must have co-morbidities such that one cardiologist and two cardiac surgeons
agree that medical factors preclude operation, based on a conclusion that the
probability of death or serious morbidity exceeds the probability of meaningful
improvement. Specifically, the predicted operative risk of death or serious,
irreversible morbidity is ≥ 50% at 30 days.

- Subjects must meet all of the criteria under at least one of the sub-groups 2a-c:

a. Senile degenerative aortic valve stenosis and i. At least one of the following
co-morbid conditions:

1. Severe (≥3-4+) mitral valve regurgitation as measured by echocardiography

2. Severe (≥3-4+) tricuspid valve regurgitation as measured by echocardiography

3. End-stage renal disease requiring renal replacement therapy (Stage 5 of the KDOQI
CKD Classification) or creatinine clearance <20cc/min but not requiring renal
replacement therapy

AND

ii. mean gradient > 40 mmHg or jet velocity greater than 4.0 m/sec by either
resting or dobutamine stress echocardiogram (if the LVEF < 50%), or simultaneous
pressure recordings at cardiac catheterization either resting or with dobutamine
stress (if the LVEF < 50%) AND iii. an initial aortic valve area of ≤ 0.8 cm2 (or
aortic valve area index ≤0.5 cm2/m2) by resting echocardiogram or simultaneous
pressure recordings at cardiac catheterization

AND/OR

b. Low gradient, low output aortic stenosis as defined by the presence of all
three of the following i. In the presence of LVEF <50%, absence of contractile
reserve, a mean gradient ≥25mmHg and <40mmHg AND jet velocity less than 4.0m/sec
with dobutamine stress echocardiography or simultaneous pressure recordings at
cardiac catheterization OR In the presence of LVEF ≥50%, a mean gradient ≥25mmHg
and <40mmHg AND jet velocity less than 4.0 m/sec, by echocardiography or
simultaneous pressure recordings at cardiac catheterization AND ii. an initial
aortic valve area of ≤0.8 cm2 (or aortic valve area index ≤0.5 cm2/m2) by resting
echocardiogram or simultaneous pressure recordings at cardiac catheterization AND
iii. radiographic evidence of severe aortic valve calcification AND/OR c. Failed
bioprosthetic surgical aortic valve

- Subject is symptomatic from his/her aortic valve stenosis, as demonstrated by New York
Heart Association (NYHA) Functional Class II or greater.

- The subject or the subject's legal representative has been informed of the nature of
the study, agrees to its provisions and has provided written informed consent as
approved by the IRB of the respective clinical site.

- The subject and the treating physician agree that the subject will return for all
required post-procedure follow-up visits.

Exclusion Criteria:

Clinical

- Evidence of an acute myocardial infarction ≤30 days before the MCS TAVI procedure.

- Any percutaneous coronary or peripheral interventional procedure performed within 30
days prior to the MCS TAVI procedure

- Blood dyscrasias as defined: leukopenia (WBC <1000mm3), thrombocytopenia (platelet
count <50,000 cells/mm3), history of bleeding diathesis or coagulopathy.

- Untreated clinically significant coronary artery disease requiring revascularization.

- Cardiogenic shock manifested by low cardiac output, vasopressor dependence, or
mechanical hemodynamic support.

- Need for emergency surgery for any reason.

- Severe ventricular dysfunction with left ventricular ejection fraction (LVEF) <20% as
measured by resting echocardiogram.

- Recent (within 6 months) cerebrovascular accident (CVA) or transient ischemic attack
(TIA).

- Active Gastrointestinal (GI) bleeding that would preclude anticoagulation.

- A known hypersensitivity or contraindication to all anticoagulation/antiplatelet
regimens (including ability to be anticoagulated for the index procedure), nitinol, or
[allergic] sensitivity to contrast media which cannot be adequately pre-medicated.

- Ongoing sepsis, including active endocarditis.

- Subject refuses a blood transfusion.

- Life expectancy <12 months due to associated non-cardiac co-morbid conditions.

- Other medical, social, or psychological conditions that in the opinion of an
Investigator precludes the subject from appropriate consent.

- Severe dementia (resulting in either inability to provide informed consent for the
study/procedure, prevents independent lifestyle outside of a chronic care facility, or
will fundamentally complicate rehabilitation from the procedure or compliance with
follow-up visits).

- Currently participating in an investigational drug or another device study.

- Symptomatic carotid or vertebral artery disease.

Anatomical

Subject has a:

- Native aortic annulus size <18 mm or >29 mm per the baseline diagnostic imaging (not
applicable for TAV in SAV subjects) OR

- Surgical bioprosthetic annulus <17mm or >29mm i. Stented SAV per the manufactured
labeled inner diameter OR ii. Stentless SAV per the baseline diagnostic imaging

- Subject has a pre-existing prosthetic heart valve with a rigid support structure in
either the mitral or pulmonic position:

1. that could affect the implantation or function of the study valve OR

2. the implantation of the study valve could affect the function of the pre-existing
prosthetic heart valve

- Moderate to severe mitral stenosis.

- Mixed aortic valve disease: aortic stenosis and aortic regurgitation with predominant
aortic regurgitation, (AR is moderate-severe to severe (≥3-4+))(except for failed
surgical bioprothesis)

- Hypertrophic obstructive cardiomyopathy.

- Echocardiographic evidence of new or untreated intracardiac mass, thrombus or
vegetation.

- Severe basal septal hypertrophy with an outflow gradient.

- Aortic root angulation (angle between plane of aortic valve annulus and horizontal
plane/vertebrae) >70° (for femoral and left subclavian/axillary access) and >30° (for
right subclavian/axillary access).

- Ascending aorta that exceeds the maximum diameter for any given native or surgical
bioprosthetic* aortic annulus size (see table below) Aortic Annulus Diameter/
Ascending Aorta Diameter, 18 mm* - 20 mm/ >34 mm, 20 mm - 23 mm/ >40 mm, 23 mm - 27
mm/ >43 mm, 27 mm - 29 mm/ >43 mm,

* 17mm for surgical bioprosthetic aortic annulus

- Congenital bicuspid or unicuspid valve verified by echocardiography (Not applicable
for TAV in SAV subjects).

- Sinus of valsalva anatomy that would prevent adequate coronary perfusion.

- Degenerated surgical bioprothesis presents with a significant concomitant perivalvular
leak (between prothesis and native annulus), is not securely fixed in the native
annulus, or is not structurally intact (e.g. wireform frame fracture) (ONLY FOR TAV in
SAV subjects)

- Degenerated surgical bioprothesis presents with a partially detached leaflet that in
the aortic position may obstruct a coronary ostium (ONLY FOR TAV in SAV subjects)

Vascular

- Transarterial access not able to accommodate an 18Fr sheath.
We found this trial at
43
sites
100 Madison Ave
Morristown, New Jersey 7960
(973) 971-5000
Principal Investigator: Robert Kipperman, MD
Morristown Memorial Hospital Atlantic Health System – comprised of Morristown Medical Center, Overlook Medical Center,...
?
mi
from
Morristown, NJ
Click here to add this to my saved trials
330 Brookline Ave
Boston, Massachusetts 02215
617-667-7000
Principal Investigator: Jeffrey J Popma, MD
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
?
mi
from
Boston, MA
Click here to add this to my saved trials
3300 Gallows Road
Falls Church, Virginia 22042
(703) 776-4001
Principal Investigator: Bryan Raybuck, MD
Inova Fairfax Hospital Inova Fairfax Hospital, Inova's flagship hospital, is an 833-bed, nationally recognized regional...
?
mi
from
Falls Church, VA
Click here to add this to my saved trials
300 Community Drive
Manhasset, New York 11030
(516) 562-0100
Principal Investigator: Stanley Katz, MD
North Shore University Hospital North Shore-LIJ Health System includes 16 award-winning hospitals and nearly 400...
?
mi
from
Manhasset, NY
Click here to add this to my saved trials
1211 Medical Center Dr
Nashville, Tennessee 37232
(615) 322-5000
Principal Investigator: Mark Robbins, MD
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
?
mi
from
Nashville, TN
Click here to add this to my saved trials
1 Gustave L Levy Pl # 271
New York, New York 10029
 (212) 241-6500
Principal Investigator: David H Adams, MD
Mount Sinai Med Ctr Founded in 1852, The Mount Sinai Hospital is a 1,171-bed, tertiary-care...
?
mi
from
New York, NY
Click here to add this to my saved trials
Ann Arbor, Michigan 48109
Principal Investigator: Stanley J Chetcuti, MD
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Atlanta, Georgia 30309
Principal Investigator: Vivek Rajagopal, MD
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
5665 Peachtree Dunwoody Rd NE
Atlanta, Georgia 30342
(678) 843-7001
Principal Investigator: Louis Heller, MD
Saint Joseph's Hospital of Atlanta Founded by the Sisters of Mercy in 1880, Saint Joseph
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
1800 Orleans St.
Baltimore, Maryland 21287
410-955-5000
Principal Investigator: Jon Resar, MD
Johns Hopkins Hospital Patients are the focus of everything we do at The Johns Hopkins...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Burlington, Vermont 05405
?
mi
from
Burlington, VT
Click here to add this to my saved trials
Cleveland, Ohio 44194
Principal Investigator: Alan Markowitz, MD
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Columbus, Ohio
Principal Investigator: Barry George, MD
?
mi
from
Columbus, OH
Click here to add this to my saved trials
3535 Olentangy River Rd
Columbus, Ohio 43214
(614) 566-5000
Principal Investigator: Steven Yakubov, MD
Riverside Methodist Hospital Serving central Ohio since 1892, Riverside Methodist Hospital is consistently ranked one...
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Dallas, Texas 75226
Principal Investigator: Robert Stoler, MD
?
mi
from
Dallas, TX
Click here to add this to my saved trials
100 North Academy Avenue
Danville, Pennsylvania 17822
570-271-6211
Principal Investigator: Kimberly Skelding, MD
Geisinger Medical Center Since 1915, Geisinger Medical Center has been known as the region’s resource...
?
mi
from
Danville, PA
Click here to add this to my saved trials
Des Moines, Iowa 50314
Principal Investigator: Atul Chawla, MD
?
mi
from
Des Moines, IA
Click here to add this to my saved trials
Detroit, Michigan
Principal Investigator: Theodore Schreiber, MD
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Detroit, Michigan 48236
Principal Investigator: Thomas Davis, MD
?
mi
from
Detroit, MI
Click here to add this to my saved trials
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Principal Investigator: J. Kevin Harrison, MD
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
?
mi
from
Durham, NC
Click here to add this to my saved trials
Grand Rapids, Michigan 49503
Principal Investigator: William Merhi, MD
?
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
80 Seymour St
Hartford, Connecticut 6102
(860) 545-5000
Principal Investigator: Raymond McKay, MD
The Hartford Hospital Hartford Hospital is the major teaching hospital affiliated with the University of...
?
mi
from
Hartford, CT
Click here to add this to my saved trials
Houma, Louisiana
Principal Investigator: Peter Fail, MD
?
mi
from
Houma, LA
Click here to add this to my saved trials
Houston, Texas 77030
Principal Investigator: Jose Diez, MD
?
mi
from
Houston, TX
Click here to add this to my saved trials
Houston, Texas
Principal Investigator: Neal S Kleiman, MD
?
mi
from
Houston, TX
Click here to add this to my saved trials
Indianapolis, Indiana 46260
Principal Investigator: James Hermiller, MD
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Kansas City, Kansas 66160
Principal Investigator: Peter Tadros, MD
?
mi
from
Kansas City, KS
Click here to add this to my saved trials
4733 Sunset Blvd
Los Angeles, California 90027
(800) 954-8000
Principal Investigator: Vicken Aharonian, MD
Kaiser Permanente Los Angeles Medical Center We've been there for you in the past, providing...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Los Angeles, California 90033
Principal Investigator: Ray Matthews, MD
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
2160 South 1st Avenue
Maywood, Illinois 60153
(888) 584-7888
Principal Investigator: Ferdinand Leya, MD
Loyola University Medical Center Loyola University Health System is committed to excellence in patient care...
?
mi
from
Maywood, IL
Click here to add this to my saved trials
Miami, Florida
Principal Investigator: Eduardo de Marchena, MD
?
mi
from
Miami, FL
Click here to add this to my saved trials
Miami Beach, Florida 33140
Principal Investigator: Nirat Beohar, MD
?
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Milwaukee, Wisconsin
Principal Investigator: Tanvir Bajwa, MD
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
20 York St, N20 York St,
New Haven, Connecticut 06520
(203) 688-4242
Principal Investigator: Craig Thompson, MD
Yale-New Haven Hospital Relying on the skill and expertise of more than 4,500 university and...
?
mi
from
New Haven, CT
Click here to add this to my saved trials
New York, New York 10016
Principal Investigator: James Slater, MD
?
mi
from
New York, NY
Click here to add this to my saved trials
New York, New York 10021
Principal Investigator: Chad Kliger, MD
?
mi
from
New York, NY
Click here to add this to my saved trials
3801 Miranda Avenue
Palo Alto, California 94304
650-493-5000
Principal Investigator: John Giacomini, MD
VA Palo Alto Health Care System The VA Palo Alto Health Care System (VAPAHCS) consists...
?
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Phoenix, Arizona
Principal Investigator: Timothy Byrne, MD
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
200 Lothrop St
Pittsburgh, Pennsylvania 15213
Principal Investigator: Joon Sup Lee, MD
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Roslyn, New York 11576
Principal Investigator: George Petrossian, MD
?
mi
from
Roslyn, NY
Click here to add this to my saved trials
Washington, District of Columbia
?
mi
from
Washington,
Click here to add this to my saved trials
1 Medical Center Blvd
Winston-Salem, North Carolina 27103
(336) 716-2011
Wake Forest University Baptist Medical Center Welcome to Wake Forest Baptist Medical Center, a fully...
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Wormleysburg, Pennsylvania 17043
Principal Investigator: William Bachinsky, MD
?
mi
from
Wormleysburg, PA
Click here to add this to my saved trials